Julian S Abrams, MD, MS
Columbia University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julian S Abrams, MD, MS as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:30 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02016820 · Effect of Acid Suppression Medication on Pediatric MicrobiomeColumbia University · terminated · Clostridium Difficile Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Multidisciplinary Training in Gastrointestinal CancersT32CA285274 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2024 to 2026 · $317,582 awarded in 2026Same name and institution; not confirmed by an ID
- The Clinical Biospecimen and Research CoreP30DK132710 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2022 to 2026 · $200,222 awarded in 2026Same name and institution; not confirmed by an ID
- The Role of Secondary Bile Acids in Gastro-Esophageal NeoplasiaR01CA272898 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2022 to 2026 · $245,000 awarded in 2026Same name and institution; not confirmed by an ID
- The Role of the Microbiome and Notch Signaling in Esophageal AdenocarcinomaR01CA255298 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2021 to 2025 · $466,166 awarded in 2025Same name and institution; not confirmed by an ID
- The Oral Microbiome for the Detection of Barretts EsophagusR01CA238433 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2019 to 2023 · $396,636 awarded in 2023Same name and institution; not confirmed by an ID
- The Role of the Microenvironment in Barrett's EsophagusU54CA163004 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2017 to 2022 · $441,975 awarded in 2022Same name and institution; not confirmed by an ID
- Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts EsophagusR03CA186218 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2015 to 2016 · $81,186 awarded in 2016Same name and institution; not confirmed by an ID
- Risk factors for site-specific metastasis in esophageal cancerK07CA132892 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · fiscal years 2008 to 2012 · $135,351 awarded in 2012Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.